Widely used chemotherapy drugs don’t attack cancer the way doctors thought, according to a UW-Madison study that identifies a new mechanism that could improve the search for new drugs and help tailor treatments for patients,
“It’s a totally different mechanism than the field had been thinking about for the last several decades,” said Beth Weaver, a UW-Madison professor of cell and regenerative biology who is senior author of the study, published recently in the journal PLOS Biology.